Home
Baytril in GeneralPoultryRuminantsPigsNews and EventsDownloads
Contact
Search
Sitemap
Bayer Links
Bayer Global
Bayer Animal Health
Baytril Companion Animal






Pigs / Efficacy / Enteritis
    

Enteritis in Piglets – Colibacillosis

Baytril's efficacy in treating E.coli diarrhoea (colibacillosis, edema disease) in piglets was tested in different trials.

20 piglets (weight range 5.2 to 6.5 kg) were experimentally infected with E.coli K88. They were divided into four groups: One received Baytril® 2.5% injectable solution i.m. (2.5 mg/kg bw on three consecutive days), the second group received Baytril® in feed (100 ppm) for 7 days, the third group received furazolidone in feed (200 ppm) for 7 days and the fourth group served as untreated control. Baytril® treatment was effective and superior to furazolidone.

Reduced clinical symptoms

Whilst in the Baytril® groups diarrhoea ended on the second day after start of treatment, in the furazolidone group diarrhoea was present till the seventh day, and two piglets died.

Reduced mortality

In the control group diarrhoea was present past the eighth day and also two piglets died.

In another trial, 30 pigs (weight range 7.3 – 19.4 kg) were divided into three groups of 10 animals each and infected with E.coli O147. Severe diarrhoea was noticed 8 hours after infection. One group received Baytril® 2.5% injectable solution i.m. (2.5 mg/kg bw on three consecutive days), the second group was treated the same way but with a dosage of 1 mg/kg bw. The third group served as controls.

Whilst in the treated groups all animals survived, the mortality of the controls raised to 80% on the eighth day after infection. The number of the pathogenic E.coli that could be isolated per g faeces dropped remarkably in the treated groups and ended after day three.

The efficacy was also tested in an outbreak of E.coli diarrhoea in suckling piglets. Baytril® was tested in dose rates of 1.25, 2.5 and 5 mg/kg bw (given as 2.5 % injectable solution applied i.m.).

The treatment success was compared with the efficacy of oxytetracycline, given at a dose rate of 10 mg/kg bw in the form of 5% injectable solution i.m.. The overall clinical efficacy was 61% for oxytetracycline, and 89%, 96% and 94% for the groups treated with 1.25, 2.5 and 5 mg/kg bw of Baytril® respectively.

Open Folder
"Enteritic disease"
(PDF File/1000 KB)




Last updated: November 19, 2008

   
Baytril in experimental E.coli infection
Baytril in experimental
E.coli infection

CFO count of E.coli
CFO count of E.coli

Clinical Efficacy
Clinical Efficacy